Emergen Research latest document, titled ‘Global In Silico Drug Discovery Market - Forecast to 2027,’ is one of the most sought-after market reports involving an in-depth analysis of the global In Silico Drug Discovery market. The report’s authors have offered necessary details on the latest In Silico Drug Discovery market trends and the crucial parameters impacting both short-term and long-term market growth. Its panoramic view of the In Silico Drug Discovery industry entails useful insights into the estimated In Silico Drug Discovery market size, revenue share, and sales distribution networks.

Key participants include Certara USA, Inc., Albany Molecular Research Inc., Chemical Computing Group ULC, Charles River, Dassault System (Biovia), Collaborative Drug Discovery Inc., Evotec A.G., ICAGEN, Inc., GVK Biosciences Private Limited, and Novo Informatics Pvt. Ltd., among others.

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/373

Another market driving the demand for intelligent drug discovery will be the availability of various options to carry out the standard options such as customization capabilities and data mining on the AI platform. However, lack of data sets in drug discovery and scarcity of skilled professionals will hinder market demand.

The in silico drug discovery is used in early preclinical research and development of small molecule drugs and in clinical candidates in various stages of medicine. Due to the advancement in information technology and innovative breakthroughs in computational chemistry, several new drug compounds are being discovered through this procedure. 

Some Key Highlights from the Report

In November 2020, Lead Pharma announced its collaboration and license agreement with Roche for the development of oral small molecules for the treatment of a broad range of immune-mediated diseases. Lead Pharma is using in silico lab for their computational chemistry, bioinformatics, and data mining activities.

The in silico molecular techniques are gaining popularity to engineer antibodies. It is used for the design of antibodies, including structure modeling, antibody stability evaluation, antibody-antigen complex prediction, and allosteric effects in antibodies and functions.

Computer-aided drug methodologies are playing a crucial role in the discovery of the drugs. This method is used in limiting the usage of animal models in pharmaceutical research, aid in the design of innovative and safe drug candidates, and supporting pharmacologist and medicinal chemist.

Usage of information technology in drug discovery is witnessing lucrative growth in the Asia Pacific region due to a rise in RD activities and development in the biotechnology and pharmaceutical sectors. Moreover, the presence of a significant patient pool will fuel the demand for better healthcare services, which will drive the demand for the market

Regional Analysis of the In Silico Drug Discovery Market:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Rapid Business Growth Factors

In addition, the market is growing at a fast pace and the report shows us that there are a couple of key factors behind that. The most important factor that’s helping the market grow faster than usual is the tough competition.

Let us know if you have any specific requirements. We offer report customization.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.

Request customization of the report: https://www.emergenresearch.com/request-for-customization/373

For the purpose of this report, Emergen Research has segmented into the global In Silico Drug Discovery Market on the workflow, product, type of large molecule, end-user, and region:

Workflow Outlook (Revenue, USD Billion; 2017-2027)

• Discovery
  1. Target Identification
     • Reverse Docking
     • Bioinformatics
     • Protein Structure Prediction
  2. Target Validation
  3. Lead Discovery
     • Pharmacophore
     • Library Design

• • Preclinical Tests
  • Clinical Trials

Product Outlook (Revenue, USD Billion; 2017-2027)

• Consultancy as a Service
• Software as a Service (Cloud)
• Software

Type of Large Molecule Outlook (Revenue, USD Billion; 2017-2027)

• Proteins
• Antibodies
• Nucleic Acids
• Peptides
• Vectors

End-User Outlook (Revenue, USD Billion; 2017-2027)

• Contract Research Organizations
• Pharmaceutical Industry
• Academic and Research Institutes
• Others

Read More: https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market

Related reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research         and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs